Definite diagnosis is based on endomyocardial biopsy and treatment of cardiac amyloidosis is a challenge. Heart transplantation, although controversial, has demonstrated survival benefit.

The prognosis of patients with cardiac amyloidosis is affected by their cardiac condition, the extracardiac involvement and the modality of treatment of the underlying disease. Another predictor ...

explains what cardiac amyloidosis is, why knowing the type of amyloid is key to treatment, and what's on the horizon to help ...

Cardiac amyloidosis is a serious disease ... death if left untreated, early diagnosis is essential in order to start treatment in good time. An international research team led by MedUni Vienna ...

In September 2001 she had severe gastrointestinal symptoms and deposits of AA ... could be an important therapy for the treatment of AA amyloidosis secondary to rheumatic disease.

After 1 July 2009, fewer transplant recipients had Mayo stage III cardiac ... based treatment or participation in clinical trials. Cohen AD, Comenzo RL . Systemic light-chain amyloidosis: advances ...

Along with treatment, complementary therapy ... The research cited an older study that found green tea reduced cardiac-related amyloidosis symptoms and amyloid plaques. Still, more research ...

Findings from this collaboration have the potential to impact not only amyloidosis but also other cardiac conditions, where non-invasive, information-rich diagnosis and monitoring are crucial.

This dual-modality technique could enable the detection of functional changes in amyloidosis and offer a better method for tracking disease progression & treatment response over time ... to impact not ...